Stay updated on HOPE-B: AMT-061 Clinical Trial
Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.

Latest updates to the HOPE-B: AMT-061 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision changed from v3.6.5 to v3.6.6, indicating a minor update to the page’s documentation/versioning. It does not reflect changes to study data or core content.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded '2017 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers to indicate NIH funding for the trial. This provides funding context without changing the trial protocol or results.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s revision number was updated from v3.6.4 to v3.6.5, signaling a small update to the page’s metadata or structure. There is no change to the study details, eligibility criteria, or results shown on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This indicates a new version of the study record page without altering the substantive content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.3, indicating a small update to the page version. This update does not modify study data or results.SummaryDifference0.0%

- Check83 days agoChange DetectedA new publication reference was added under Publications: Parman T, Pizzurro DM, Lucas J, Peng Z. Mutagenesis and Carcinogenesis Risk Evaluation for AAV and Lentiviral Gene Therapies. Int J Toxicol. 2025 May-Jun;44(3):183-195. This addition expands the study's literature context by linking HOPE-B to broader gene therapy risk evaluation literature.SummaryDifference0.0%

Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.